Hogenhuis Wladimir 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Hogenhuis Wladimir
Chief Operating Officer
Transactions
- Award
Common Stock
2019-03-01+5,000→ 20,000 total - Award
Stock Option (Right to Buy)
2019-03-01+11,000→ 11,000 totalExercise: $67.55Exp: 2029-03-01→ Common Stock (11,000 underlying)
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.